DIA449.02+1.91 0.43%
SPX6,388.64+25.29 0.40%
IXIC21,108.32+50.36 0.24%

This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday

Benzinga·07/21/2025 12:32:44
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Needham analyst Gil Blum downgraded the rating for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) from Hold to Underperform. Sarepta Therapeutics shares closed at $14.07 on Friday. See how other analysts view this stock.
  • Barclays analyst Seth Sigman downgraded Target Corporation (NYSE:TGT) from Equal-Weight to Underweight and announced a $91 price target. Target shares closed at $103.46 on Friday. See how other analysts view this stock.
  • Leerink Swann analyst Mani Foroohar downgraded Sarepta Therapeutics, Inc. (NASDAQ:SRPT) from Outperform to Market Perform and cut the price target from $45 to $10. Sarepta Therapeutics shares closed at $14.07 on Friday. See how other analysts view this stock.
  • Truist Securities analyst Patrick Scholes downgraded Royal Caribbean Cruises Ltd. (NYSE:RCL) from Buy to Hold but raised the price target from $275 to $337. Royal Caribbean shares closed at $350.10 on Friday. See how other analysts view this stock.
  • TD Cowen analyst Ryan Langston downgraded Centene Corporation (NYSE:CNC) from Buy to Hold and cut the price target from $73 to $33. Centene shares closed at $27.95 on Friday. See how other analysts view this stock.

Considering buying TGT stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.